Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name JX-594
Trade Name
Synonyms Pexastimogene devacirepvec|JX594|Pexa-vec|TG-6006
Drug Descriptions

Pexastimogene devacirepvec (JX-594) is a thymidine kinase-inactivated oncolytic vaccinia virus expressing human GM-CSF, which selectively infects transformed cells and induces cell death (PMID: 22186794).

CAS Registry Number 1058624-46-6
NCIT ID C71533


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Avelumab + Cyclophosphamide + JX-594 Avelumab Cyclophosphamide JX-594 0 1
Cemiplimab + JX-594 Cemiplimab JX-594 0 1
Cyclophosphamide + JX-594 Cyclophosphamide JX-594 0 1
Ipilimumab + JX-594 Ipilimumab JX-594 0 1
JX-594 JX-594 0 1
JX-594 + Sirolimus JX-594 Sirolimus 0 0
JX-594 + Sorafenib JX-594 Sorafenib 0 0
JX-594 + Sunitinib JX-594 Sunitinib 0 0

Additional content available in CKB BOOST